James J. Peters VA Medical Center — The Bronx, New York

Public research footprint of James J. Peters VA Medical Center, compiled from the ClinicalTrials.gov public registry.

165

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIIB Lung Cancer AJCC v8 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIA Lung Cancer AJCC v8 · Stage II Lung Non-Small Cell Cancer AJCC v7

Recently updated registry entries

NCT02595944 — Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA… (Active Not Recruiting)
NCT03793179 — Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment… (Active Not Recruiting)
NCT03055013 — Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at James J. Peters VA Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.